To assess the effects of systemic therapies on the prevention or management of AIMSS in patients with Stage I-III hormone receptor-positive breast cancer.
This is a protocol.
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
Health topics:
Share